by John Leifer | Feb 8, 2016 | Healthcare, Healthcare reform, Pharmaceutical, Transparency
This article, from the Business Journal, calls on candidates to go far beyond simply bashing Obamacare and articulate a cogent path to a value-driven health care system....
by John Leifer | Dec 15, 2014 | Healthcare, Healthcare reform
Each year, the Access to Medicine Foundation publishes a hierarchical list of pharmaceutical companies ranked on their efforts to “improve access to medicine in developing countries.” See: http://www.accesstomedicineindex.org/ranking. Without wanting to diminish the...
by John Leifer | Apr 30, 2014 | Healthcare, Healthcare reform
“Health is Priceless:” A recent article in the New York Times stated that pharmaceutical companies are employing a new rationale to justify the seemingly irrationally, exorbitant prices being charged for pharmaceuticals: “Health is priceless.” While true,...
Recent Comments